Hsp90: the vulnerable chaperone

被引：187

作者：

Chiosis, G ^{[1
]}

Vilenchik, M ^{[1
]}

Kim, J ^{[1
]}

Solit, D ^{[1
]}

机构：

[1] Mem Sloan Kettering Canc Ctr, Dept Med, New York, NY 10021 USA

来源：

DRUG DISCOVERY TODAY | 2004年 / 9卷 / 20期

关键词：

D O I：

10.1016/S1359-6446(04)03245-3

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

The molecular chaperone Hsp90 has emerged as an important target in cancer treatment because of its roles in maintaining transformation and regulating the function of proteins involved in apoptotic, survival and growth pathways. Many Hsp90 inhibitors function by binding to the N-terminal ATP pocket, but the chaperone has many other vulnerable points. Agents that interact with its C-terminus or modify its post-translational status represent additional ways of interfering with chaperone activity. This review will discuss several emerging classes of Hsp90 inhibitors and their modes of action.

引用

页码：881 / 888

页数：8

共 60 条

[1]

AHERNE W, 2003, 9J ANN M AACR 11 14

[2]

Atadja Peter, 2004, Novartis Found Symp, V259, P249

[3]

Banerji U., 2003, P AM ASSOC CANC RES, V44, P677

[4]

BARBOSA JA, 2003, S CLIN CANC RES, V9

[5]

Blank M, 2003, CANCER RES, V63, P8241

[6] 17-(Allylamino)-17-demethoxygeldanamycin activity in human melanoma models [J].

Burger, AM ;

Fiebig, HH ;

Stinson, SF ;

Sausville, EA .

ANTI-CANCER DRUGS, 2004, 15 (04) :377-387

[7] ATPases as drug targets:: Learning from their structure [J].

Chène, P .

NATURE REVIEWS DRUG DISCOVERY, 2002, 1 (09) :665-673

[8] A small molecule designed to bind to the adenine nucleotide pocket of Hsp90 causes Her2 degradation and the growth arrest and differentiation of breast cancer cells [J].

Chiosis, G ;

Timaul, MN ;

Lucas, B ;

Munster, PN ;

Zheng, FF ;

Sepp-Lorenzino, L ;

Rosen, N .

CHEMISTRY & BIOLOGY, 2001, 8 (03) :289-299

[9] Development of a purine-scaffold novel class of Hsp90 binders that inhibit the proliferation of cancer cells and induce the degradation of Her2 tyrosine kinase [J].

Chiosis, G ;

Lucas, B ;

Shtil, A ;

Huezo, H ;

Rosen, N .

BIOORGANIC & MEDICINAL CHEMISTRY, 2002, 10 (11) :3555-3564

[10] Development of Purine-Scaffold Small Molecule Inhibitors of Hsp90 [J].

Chiosis, Gabriela ;

Lucas, Brian ;

Huezo, Henri ;

Solit, David ;

Basso, Andrea ;

Rosen, Neal .

CURRENT CANCER DRUG TARGETS, 2003, 3 (05) :371-376

← 1 2 3 4 5 6 →